These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 31049986)

  • 1. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites.
    Attia MF; Anton N; Wallyn J; Omran Z; Vandamme TF
    J Pharm Pharmacol; 2019 Aug; 71(8):1185-1198. PubMed ID: 31049986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive and active tumour targeting with nanocarriers.
    Hirsjärvi S; Passirani C; Benoit JP
    Curr Drug Discov Technol; 2011 Sep; 8(3):188-96. PubMed ID: 21513482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches.
    Malliappan SP; Kandasamy P; Chidambaram S; Venkatasubbu D; Perumal SK; Sugumaran A
    Anticancer Agents Med Chem; 2020; 20(11):1300-1310. PubMed ID: 31642415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
    Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
    Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and challenges towards targeted delivery of cancer therapeutics.
    Rosenblum D; Joshi N; Tao W; Karp JM; Peer D
    Nat Commun; 2018 Apr; 9(1):1410. PubMed ID: 29650952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.
    Das RP; Gandhi VV; Singh BG; Kunwar A
    Curr Pharm Des; 2019; 25(28):3034-3056. PubMed ID: 31470779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead.
    Akhter MH; Beg S; Tarique M; Malik A; Afaq S; Choudhry H; Hosawi S
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129777. PubMed ID: 33130062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actively targeted nanocarriers for drug delivery to cancer cells.
    Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
    Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
    Sultana S; Khan MR; Kumar M; Kumar S; Ali M
    J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart Mesoporous Silica Nanocarriers for Antitumoral Therapy.
    Baeza A; Vallet-Regí M
    Curr Top Med Chem; 2015; 15(22):2306-15. PubMed ID: 26043739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.